2026-09-24T15:51:22Zhttps://wakespace.lib.wfu.edu/server/oai/request

oai:null:10339/393072026-09-02T15:33:36Zcom_10339_14934col_10339_38132

Arter, Alison 2014-07-10T08:35:38Z 2015-07-10T08:30:09Z 2014 https://wakespace.lib.wfu.edu/handle/10339/39307 Approximately 40,000 women in the U.S. die from breast cancer annually. An estimated 15% of all breast cancers are triple negative, wherein tumors lack estrogen receptor and progesterone receptor expression and possess unamplified human epidermal growth factor receptor 2 (HER2) levels, contributing to an absence of effective, targeted therapeutics. Furthermore, triple negative breast cancer (TNBC) is highly-aggressive with greater patient mortality rates compared with other breast cancer subtypes, necessitating development of novel treatment options. en Wake Forest University Molecular Mechanisms for the Angiotensin-(1-7)-Mediated Inhibition of Metastatic Triple Negative Breast Cancer Dissertation Tallant, Ann Metheny-Barlow, Linda Miller, Mark S Levi-Polyachenko, Nicole H Physiology and Pharmacology 2015-07-10 open.access